Conceptus Receives FDA Approval for Compatible Use of Hologic's NovaSure with Essure Inserts in Place

Conceptus, Inc. CPTS announced today that the U.S. Food and Drug Administration approved labeling changes pertaining to the use of bipolar radio frequency NovaSure® Impedance Controlled Endometrial Ablation System(1) following the placement of Essure inserts and a successful Essure Confirmation Test. The expanded label change followed the Company and the FDA reaching an agreement on the post-approval study protocol.